Bacteroides thetaiotaomicron Outer Membrane Vesicles Modulate Virulence of Shigella flexneri von Xerri, Nicholas L, Payne, Shelley M

Volltext

Gene expression profiling of breast cell lines identifies potential new basal markers von CHARAFE-JAUFFRET, E, GINESTIER, C, BERTUCCI, F, MONVILLE, F, FINETTI, P, ADELAÏDE, J, CERVERA, N, FEKAIRI, S, XERRI, L, JACQUEMIER, J, BIRNBAUM, D

Volltext

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes von Laurent, C., Delas, A., Gaulard, P., Haioun, C., Moreau, A., Xerri, L., Traverse-Glehen, A., Rousset, T., Quintin-Roue, I., Petrella, T., Emile, J.F., Amara, N., Rochaix, P., Chenard-Neu, M.P., Tasei, A.M., Menet, E., Chomarat, H., Costes, V., Andrac-Meyer, L., Michiels, J.F., Chassagne-Clement, C., de Leval, L., Brousset, P., Delsol, G., Lamant, L.

Volltext

EZH2 alterations in follicular lymphoma: biological and clinical correlations von Huet, S, Xerri, L, Tesson, B, Mareschal, S, Taix, S, Mescam-Mancini, L, Sohier, E, Carrère, M, Lazarovici, J, Casasnovas, O, Tonon, L, Boyault, S, Hayette, S, Haioun, C, Fabiani, B, Viari, A, Jardin, F, Salles, G

Volltext

Nature and importance of follicular lymphoma precursors von Mamessier, Emilie, Broussais-Guillaumot, Florence, Chetaille, Bruno, Bouabdallah, Reda, Xerri, Luc, Jaffe, Elaine S, Nadel, Bertrand

Volltext

Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias von Carbuccia, N, Trouplin, V, Gelsi-Boyer, V, Murati, A, Rocquain, J, Adélaïde, J, Olschwang, S, Xerri, L, Vey, N, Chaffanet, M, Birnbaum, D, Mozziconacci, M J

Volltext

Comparison of machine learning approaches for POD24 prediction based on pretreatment PET in follicular lymphoma patients (on behalf of CALYM/LYSA groups) von Hoang, D. T., Schalck, E., Ricci, R., Chartier, L., Marlot, L., Gomez, E., Nadel, B., Xerri, L., Morschhauser, F., Kanoun, S., Rossi, C.

Volltext

Identification of an activated/memory B‐cell signature of poor outcome and sensitivity to lenalidomide in follicular lymphoma patients von Laurent, C., Trisal, P., Tesson, B., Lesne, B., Van‐Acker, N., Chartier, L., Stokes, M., Huang, C., Huet, S., Morschhauser, F., Gandhi, A. K, Xerri, L.

Volltext

Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity von Garciaz, S, Coso, D, Schiano de Collela, J-M, Broussais, F, Stoppa, A-M, Aurran, T, Chabannon, C, Helvig, A, Xerri, L, Blaise, D, Bouabdallah, R

Volltext

RESISTANCE OF B‐CELL LYMPHOMAS TO CAR‐T CELL THERAPY IS ASSOCIATED WITH HISTOPHENOTYPICAL AND GENOMIC TUMOR CHANGES WHICH CAN INDUCE PROFOUND TRANS‐DIFFERENTIATION von Laurent, C., Hamon, M., Syrykh, C., de Adélaï, J., Guille, A., Parrens, M., Dartigues, P., Bardet, A., Mescam, L., Schiano De Colella, J.‐M., Sujobert, P., Besson, C., Birnbaum, D., Xerri, L.

Volltext

Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas von BALLESTER, B, RAMUZ, O, MOZZICONACCI, M-J, BIRNBAUM, D, BROUSSET, P, BERGER, F, SALLES, G, BRIERE, J, HOULGATTE, R, GAULARD, P, XERRI, L, GISSELBRECHT, C, DOUCET, G, LOÏ, L, LORIOD, B, BERTUCCI, F, BOUABDALLAH, R, DEVILARD, E, CARBUCCIA, N

Volltext

469 OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma von Ouafik, L, Berenguer, C, Cayol, M, Astorgues-Xerri, L, Bekradda, M, Odore, E, Rezai, K, Riveiro, M.E, Cvitkovic, E

Volltext

MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT von Cavalieri, D., Tournilhac, O., Missiglia, E., Bonnet, C., Ledoux‐Pilon, A., Bisig, B., Cairoli, A., Poullot, E., Fataccioli, V., Parrens, M., Copin, M. C., Gutierrez, F. Llamas, Xerri, L., Bossard, C., De Wind, R., Drieux, F., Lhomme, F., Daniel, A., Clément‐Filliatre, L., Lemmonier, F., Morel, P., Noël, R., Brotelle, T., Glaisner, S., Sibon, D., El Yamani, A., Bologna, S., Queru, K., Damaj, G., Letailleur, V., Villemagne, B., Fleck, E., Dupont, E., Tchernonog, E., Monjanel, H., de Wilde, V., Vallois, D., Gaulard, P., de Leval, L.

Volltext

567 OTX015, a BET-bromodomain (BET-BRD) inhibitor, potentiates the in vitro effects of chemotherapy drugs and targeted agents in human leukemic cell lines von Astorgues-Xerri, L, Canet-Jourdan, C, Bekradda, M, Cvitkovic, E, Herait, P, Raymond, E, Riveiro, M

Volltext

587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines von Odore, E, Astorgues-Xerri, L, Bekradda, M, Cvitkovic, E, Herait, P, Lokiec, F, Rezai, K, Riveiro, M

Volltext

565 Preclinical evaluation of OTX015, a novel BET-BRD inhibitor, on small cell lung cancer (SCLC) cell lines von Ijaz, N, Astorgues-Xerri, L, Odore, E, Bekradda, M, Cvitkovic, E, Noel, K, Raymond, E, Riveiro, M

Volltext

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer von LETESSIER, A, GARRIDO-URBANI, S, VIENS, P, CHARAFE -JAUFFRET, E, JACQUEMIER, J, BIRNBAUM, D, LOPEZ, M, CHAFFANET, M, GINESTIER, C, FOURNIER, G, ESTERNI, B, MONVILLE, F, ADELAÏDE, J, GENEIX, J, XERRI, L, DUBREUIL, P

Volltext

JAK‐STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI‐ALCL PATHOGENESIS? von Laurent, C., Nicolae, A., Laurent, C., Le Bras, F., Haioun, C., Fataccioli, V., Amara, N., Adélaïde, J., Guille, A., Schiano De Colella, J., Tesson, B., Traverse‐Glehen, A., Chenard, M., Mescam, L., Moreau, A., Chassagne‐Clément, C., Somja, J., Escudié, F., André, M., Martin, N., Hamy‐Petit, A., Reyal, F., Croix, M., Birnbaum, D., Brousset, P., Xerri, L., Gaulard, P.

Volltext

580 Evaluation of the pan-BET-bromodomain inhibitor OTX015 as a single agent and in combination with everolimus (RAD001) in triple-negative breast cancer models von Vázquez, R, Astorgues-Xerri, L, Riveiro, M.E, Di Marino, M, Beltrame, L, Bekradda, M, Cvitkovic, E, Erba, E, Frapolli, R, D'Incalci, M

Volltext

P1133: SUB‐CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW‐TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE II... von Cartron, G., Bachy, E., Tilly, H., Daguindau, N., Pica, G.‐M., Bijou, F., Mounier, C., Clavert, A. M., Damaj, G. L., Slama, B., Casasnovas, O., Houot, R., Bouabdallah, K., Sibon, D., Fitoussi, O., Morineau, N., Herbaux, C., Gastinne, T., Fornecker, L.‐M., Haioun, C., Launay, V., Araujo, C., Benbrahim, O., Sanhes, L., Gressin, R., Gonzalez, H., Morschhauser, F., Xerri, L., Tarte, K., Pranger, D.

Volltext